ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0RI2 Airway Medix Sa

0.58
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Airway Medix Sa LSE:0RI2 London Ordinary Share PLAIRWY00017 AIRWAY MEDIX ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.58 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 520k -3.28M -0.0536 -10.82 35.45M

Israeli BICI Solutions to take over the management role of Polish Airway Medix Group

22/06/2022 6:29pm

PR Newswire (US)


Airway Medix (LSE:0RI2)
Historical Stock Chart


From Dec 2021 to Dec 2024

Click Here for more Airway Medix Charts.

TEL AVIV, Israel and WARSAW, June 22, 2022 /PRNewswire/ -- BICI Solutions, an Israeli strategic consulting with wide international connections, entered as a new investor in Airway Medix S.A. (WSE: AWM) and gradually will take over the day-to-day management of Airway Medix and its Subsidiary Biovo Technologies.

The BICI Solutions team will implement a new strategy which includes completion of Hyperform™ platform technology and expansion of Biovo's existing sales channel network, building Biovo's position as global leader in the Intensive Care and Anesthesia market sector.

Airway Medix's Cuffix™ and Oral Care™ are already distributed in four continents and a clinical trial is set to begin in the US as the cornerstone for the future introduction of Cuffix to the American market.

The COVID 19 pandemic has vastly increased worldwide demand for paradigm changing ICUs products and the entrance of BICI will enable Biovo Technologies and Airway Medix to meet the growing demand.

BICI Solutions aims to maximize Airway Medix's shareholders value through product sales expansion, completion of pipeline development and opportunistically collaborate with complementary products/companies.

"I am convinced of the potential of its unique and proprietary portfolio. I believe the current price of AWM shares on the Warsaw Stock Exchange may be significantly undervalued. The intense relations of our team with investors so far show that their comprehensive education, engagement of smart capital and increase of the company's exposure to the Israeli and the US financial markets can lead to improved target valuation - with a premium for shareholders," says Shai Braitner, Founder and CEO of BICI.

About BICI:

BICI Solutions is an Israeli consulting company specializing in supporting international clients, investing, among others, in Israel. The company's team consists of business, financial and industry advisors, negotiation experts, BI experts and with over 15 years of experience in business and the public sector. BICI Solutions is also supported by external consultants with experience in the healthcare industry, the medical devices sector, and financial markets. www.bici-solutions.com.

BICI clients represent the private as well as public sector. The consultancy has been involved in recent years in several large-scale projects focused on the restructuring, recovery, funding, and management of Israeli and international enterprises.

Airway Medix S.A. (WSE: AWM) focuses on research and development work and commercialization of innovative, disposable devices for the mechanically ventilated patients in the Intensive Care Units (ICU), and for the patients in life-threatening conditions in the anesthesiology departments.

Products presented by Airway Medix address the immediate clinical needs and make up for the shortcomings in the area of currently applied medical devices. They provide the patients, their careers and healthcare financing institutions with considerable clinical and economic benefits. The Company conducts research and development work in a R&D laboratory certified according to (ISO 13485:2003 & EN ISO 13485:2012) located in Israel, www.biovo-tech.com.

For further details, please contact:
Mr. Ronen Grossman
Biovo Investor Relations
+972 72 2151 115
ir@biovo.com 

Cision View original content:https://www.prnewswire.com/news-releases/israeli-bici-solutions-to-take-over-the-management-role-of-polish-airway-medix-group-301573336.html

SOURCE Airway Medix S.A.; BICI Solutions

Copyright 2022 PR Newswire

1 Year Airway Medix Chart

1 Year Airway Medix Chart

1 Month Airway Medix Chart

1 Month Airway Medix Chart

Your Recent History

Delayed Upgrade Clock